The development of a web-based information tool for cross-border prevention and control of Methicillin Resistant Staphylococcus aureus
AbstractIncreased international trade in health services and particularly patients and health care givers crossing European borders can have an important role in the rapid spread of health care associated infections, such as methicillin-resistant Staphylococcus aureus (MRSA). Therefore, the project EUREGIO MRSA-net Twente/Münsterland, in which local health care providers exchange knowledge and technology, aims to equalize quality criteria to reduce cross-border MRSA spread. Since it launch in 2005, the project has now established a cross-border infrastructure of which a web-based MRSA tool is part (www.mrsa-net.nl). This web-based tool should facilitate health care workers with acceptable, applicable, user-friendly information and evidence-based guidelines that enhance the decision making process and enable them to deliver safe health care. We applied a user-centered design approach to develop this web-based tool. The approach included a pre-design phase with a deep qualitative analysis of Dutch and German health care workers’ needs and their current activity and work habits, to ensure that the web-based tool will be successfully integrated in their daily work practice. In the design phase, five different methods were used to create a web-based tool completely based on user needs. For instance, Scenario Testing and Card Sorting provided us with insights in the thinking and acting of health care workers, which helped us to fully adapt the tool to the user needs. Moreover, we found that involving users is important to create ownership and to foster the applicability of the tool. The involvement of key players and users is important to ensure that the tool’s content is in accordance with existing guidelines. By providing health care workers with our tool, we aspire to enhance cross-border patient safety.
Copyright conditions: Copyright on any research article in the International Journal of Infection Control (IJIC) is retained by the author(s). Authors grant IJIC permission to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. IJIC conforms to the Creative Commons Attribution License (http://creativecommons.org) as terms and conditions of publishing research articles. In summary, anyone is free: • to copy, distribute, and display the work; • to make derivative works; • to make commercial use of the work; as long as: • the original author must be given credit; • for any reuse or distribution, it must be made clear to others what the license terms of this work are; • any of these conditions can be waived if the authors gives permission. Statutory fair use and other rights are in no way affected by the above. Authors' certification: In submitting a manuscript to IJIC, authors are requested to certify that: • They are authorized by their co-authors to enter into these arrangements. • They warrant, on behalf of themselves and their co-authors, that: o the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights; o they are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to IJIC are not in breach of any other obligation. If the law requires that the article be published in the public domain, they will notify IJIC at the time of submission; o the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy; o they have taken due care to ensure the integrity of the article.